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INTRODUCTION
Staphylococcus aureus is one of the most common causes of
nosocomial infection and community-acquired infection. Anti-
microbial resistance has been a problem primarily in the heal-
thcare setting. In recent years, however, community-acquired
S. aureus infection has been a problem due to the rapidly in-
creasing emergence and spread of antimicrobial resistance
(1-4). In the United States, S. aureus infections associated with
skin and soft tissue infection (SSTI) in the community-acqu-
ired settings showed a methicillin resistance rate higer than
50%, and the initial treatment with glycopeptide for severe
SSTI was recommended (3, 5). A few groups have investigated
the proportion of clinical isolates of S. aureus that are of me-
thicillin-resistant Staphylococcus aureus (MRSA) among non-
hospitalized or hospitalized patients in Korea (6-10). In the
United States, a an article was recently reported about MRSA
infections among patients in the Emergency Department
(ED) (11). However, there have been no data published about
the prevalence of MRSA bacteremia in the ED. 
In ED settings, where the initial triage of patients occurs,
the diagnosis of bacteremia is presumptive, and antimicro-
bial agents are often prescribed empirically. It is important
to select appropriate antibiotics for patients admitted to the
ED. Several studies have demonstrated that appropriate em-
pirical antibiotic treatment had a favorable effect on the out-
come in patients with S. aureus bacteremia (SAB) (12, 13).
Many physicians have difficulties in deciding whether van-
comycin or other glycopeptides should be included in the
empirical antibiotic regimen until preliminary microbiolo-
gy reports become available (1, 2). Identification of risk fac-
tors that are associated with the presence of methicillin resis-
tance in S. aureus isolates recovered from patients with bac-
teremia could help infection control efforts and in choosing
empirical therapeutic agents with pending culture and sus-
ceptibility results.
We performed this study to reveal the prevalence and char-
acteristics of MRSA isolates, and the risk factors that are
associated with methicillin resistance among SAB patients
in the ED to give better information about the choice of
empirical therapeutic agents for suspicious SAB patients.
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Analysis of Methicillin Resistance among Staphylococcus aureus
Blood Isolates in an Emergency Department 
The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA)
has become of great concern in both hospital and community settings. To evaluate
the prevalence and risk factors for methicillin resistance among Staphylococcus
aureus, blood isolates in our Emergency Department (ED) were collected. All pa-
tients with S. aureus bacteremia (SAB) who presented to the ED from January
2000 to August 2005 were included, and a retrospective study was performed. A
total of 231 patients with SAB were enrolled (median age, 59 yr; M:F, 125:106).
Among these patients, methicillin-resistant strains accounted for 27.3% (63 pati-
ents). Catheter-related infection was the most frequent primary site of SAB (39.0%),
followed by skin and soft tissue infection (16.5%). In multivariate analysis, recent
surgery (OR, 3.41; 95% CI, 1.48-7.85), recent hospitalization (2.17; 1.06-4.62), and
older age (≥61 yr) (2.39; 1.25-4.57) were independently associated with the acqui-
sition of methicillin-resistant strains. When antimicrobial therapy is considered for
the treatment of a patient with suspected SAB, clinicians should consider obtain-
ing cultures and modifying empirical therapy to provide MRSA coverage for patients
with risk factors: older age, recent hospitalization, and recent surgery. 
Key Words : Staphylococcus aureus; Community-acquired Infections; Methicillin Resistance; Risk Factors
Received : 11 September 2006
Accepted : 18 December 2006MRSA in ER 683
MATERIALS AND METHODS
Study population
Our study was based on all adults who had visited the ED
at the Samsung Medical Center (SMC) in Korea. The SMC
is a tertiary-care teaching hospital with 1,350 hospital beds.
The hospital provides specialized medical and surgical care,
including bone marrow and solid organ transplantation, for
children and adult patients. The annual ED census is approx-
imately 55,000 visits.
All patients admitted through the ED who had S. aureus
recovered from blood cultures (1 or more sets) within the first
72 hr of their hospital stay were included by means of a ret-
rospective review of medical records and of the electronic
records of the Clinical Microbiology Laboratory between 1 Jan-
uary 2000 and 31 August 2005. A retrospective case-control
analysis was made on all patients. Those patients with SAB
as part of polymicrobial bloodstream infection (BSI) were
excluded. 
Microbiological tests
The recovery of S. aureus isolates from blood was accom-
plished by the processing of blood cultures in the BACTEC
Model 9240 (BD Diagnostic Instrument Systems, 7 Love-
ton Circle, Sparks, MD, U.S.A.) or BacT/ALERT 3D (Bio-
Merieux Inc., Hazelwood, MO, U.S.A.). Identification of S.
aureus was carried out using standard methods (coagulase
test and latex kit test). Antibiotic susceptibility test of S.
aureus isolates was performed on the VITEK II automated
system with GPI Cards (BioMerieux) using the modified
broth microdilutional method. Minimum inhibitory con-
centration breakpoints and quality-control protocols were
used according to standards established by the Clinical and
Laboratory Standards Institute (14).
Definitions
Patients were considered to have staphylococcal BSI when
one or more blood cultures were positive for S. aureus and
when the clinical course was consistent with staphylococcal
infection (that is, the clinicians or the infectious disease con-
sultant judged the organism to be a pathogen), and when the
antibiotic therapy directed against the organism was admin-
istered.
Among the primary foci of infection, catheter-related infec-
tion was defined according to the IDSA guidelines (15);
infective endocarditis was defined according to the modified
Duke criteria (16); skin and soft tissue infection, bone and
joint, lung, gastrointestinal or genitourinary lesion were
defined when such sites were found with clinical findings or
imaging abnormalities and S. aureus strains were isolated from
blood and/or those sterile specimens (17).
The status of the following parameters was determined
based on medical records and the electronic records of the
Clinical Microbiology Laboratory: age, sex, underlying ill-
ness, history of hospitalization, operation and mechanical
ventilation care within previous 1 yr, existence of implanted
catheter, patient outcomes including mortality, and antimi-
crobial susceptibilities of the microorganisms. 
Statistical analysis
In order to identify the risk factors associated with methi-
cillin resistance in SAB, data were compared between two
groups, patients with MRSA and those with MSSA. The
results were analyzed using the SPSS 11.0 for Windows soft-
ware package (SPSS Inc, Chicago, IL, U.S.A.). The categori-
cal variables were compared using a Pearson  2-test or Fish-
er’s exact test, as appropriate, and the continuous variables
were analyzed with Student’s t-test or the Mann-Whitney
U-test. Predictor variables associated with MRSA infection
were initially assessed by univariate analysis. Factors found
to be associated with MRSA bacteremia by univariate analysis
were then analyzed by multivariate analysis to identify any
significant independent associations. A two-tailed p value of
less than 0.05 was considered to be statistically significant.
Ethical considerations
This study was approved by the Institutional Review Board
at Samsung Medical Center (# 2006-04-025). Informed con-
sent form from patients was waived because no direct patient
contact was anticipated and no follow-up interviews were
conducted. All data collected for the purpose of this study
were kept confidential.
RESULTS
During this study period, 630 cases of SAB were identi-
fied in the ED. A total of 399 episodes of SAB were exclud-
ed because they represented recurrent SAB in the same patient,
or demonstrated a single culture without significant signs
of infection, or the strain was identified after 72 hr. Thus, a
total of 231 patients with SAB were analyzed. 
Of the 231 patients, 168 (72.7%) isolates were MSSA.
MRSA accounted for 27.3% (63 patients) of SAB. Fig. 1
shows the proportion of MRSA isolates among SAB per study
year. The proportion of MRSA isolates recovered from the
blood within 72 hr of the ED visit increased significantly over
the study period; from 12-24% during 2000-2001 to 34-
38% during 2004-2005 (p=0.019). 
The incidence of MRSA was significantly higher among
older (especially ≥61 yr) patients (p=0.003). Catheter-related
BSIs were the most frequent known underlying sources of
SAB (39.0%), followed by SSTI (16.5%) and bone and joint684 S.T. Heo, K.R. Peck, S.Y. Ryu, et al.
infections (13.0%). There was no significant difference bet-
ween the two groups in primary foci of SAB, even though
the frequency of MRSA tended to be higher among catheter-
related BSI (Table 1).
Factors associated with an increased risk for recovery of MR-
SA strains by univariate analysis were: age over 61 yr, the
presence of any type of catheter (central venous catheter, uri-
nary catheter etc.) at the time of ED visit, previous hospital-
ization or a history of surgical procedure, or use of mechani-
cal ventilation within the past 1 yr (Table 2). Using multi-
variate analysis, a history of recent surgery (OR, 3.41; 95%
CI, 1.47-7.85), recent hospitalization (2.17; 1.06-4.62), and
older age (2.39; 1.25-4.57) were each independently associ-
ated with MRSA bacteremia (Table 3). Fifty nine (93.7%)
of 63 patients with MRSA bacteremia had at least one of the
independent risk factors described above. Ten (83.3%) of 12
patients who had all three risk factors were found to have
MRSA bacteremia. 
While MSSA strains remained susceptible to various anti-
microbial agents, MRSA strains were resistant to many anti-
microbials. Among MRSA isolates, there were 51 (81.0%)
that were multidrug resistant (resistance to three or more
antimicrobials). All 63 MRSA isolates were susceptible to
vancomycin. In contrast to the high resistance rates to other
antimicrobials, 90.6% and 84.1% of MRSA isolates were
susceptible to rifampin and trimethoprim/sulfamethoxazole
(TMP/SMX), respectively. 
The crude mortality rate of patients who had S. aureus iso-
lated from blood cultures within 72 hr of arrival in the ED
was 22.5%. The crude mortality rate did not differ signifi-
cantly between patients with MRSA and MSSA bacteremia,
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Fig. 1. The proportion of MRSA among S. aureus isolates recov-
ered from the blood within 72 hr of ED visit for the study years. The
dashed line is a trend bar of proportions. MRSA, methicillin-resis-
tant S. aureus.
MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S.
aureus; SD, standard deviation.
Characteristics
MRSA
(N=63)
MSSA
(N=168)
p value
Age mean±SD (yr) 52±21.0 59±16.2 0.008
Age groups, n (%)
20 yr 19 (11.3) 1 (1.6) 0.116
21-40 yr 20 (11.9) 7 (11.1) 0.090
41-60 yr 58 (34.5) 19 (30.2) 0.084
≥61 yr 71 (42.3) 36 (57.1) 0.003
Male:female (n) 88:80 37:26 0.388
Mortality, n (%) 33 (19.6) 19 (30.2) 0.088
Site of infection
Catheter-related 61 (36.3) 29 (46.0) 0.381
Skin & soft tissue 29 (17.3) 9 (14.3) 0.770
Bone & joint 26 (15.5) 4 (6.3) 0.047
Lung 5 (3.6) 5 (7.9) 0.124
Heart 11  (6.5) 5  (7.9) 0.734
Genitourinary systems 9 (5.4) 5 (7.9) 0.610
Gastrointestinal systems 2 (1.2) 3 (4.8) 0.125
Unknown 25 (14.3) 3 (4.8) 0.136
Table 1. Clinical characteristics of patients with S. aureus bacte-
remia
Risk factors OR 95% CI p value
Age (≥61 yr) 2.39 1.25-4.57 0.008
Catheterization 1.82 0.96-3.45 0.067
Hospitalization 2.17 1.02-4.62 0.045
Operation 3.41 1.48-7.85 0.004
Mechanical ventilation 4.27 0.76-23.57 0.097
Table 3. Multivariate analysis of risk factors associated with MR-
SA bacteremia
MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant
S. aureus; CNS, central nervous system; OR, odds ratio; CI, confidence
interval.
*History within 1 yr. 
MRSA, methicillin-resistant S. aureus; OR, odds ratio; CI, confidence
interval.
Risk factors
MRSA, 
n (%)
(N=63)
MSSA, 
n (%)
(N=63)
p value OR (95%CI)
Catheterization 61 (36.3) 33 (52.4) 1.93 (1.07-3.47) 0.027
Malignancy 77 (45.8) 24 (38.1) 0.73 (0.42-1.36) 0.291
CNS Ds. 12 (7.1) 7 (11.1) 1.63 (0.61-4.33) 0.328
Cardiac diseases 28 (16.7) 16 (25.4) 1.70 (0.85-3.42) 0.132
Lung diseases 4 (2.4) 3 (4.8) 2.05 (0.45-9.43) 0.394
Liver diseases 14 (8.3) 4 (6.3) 0.75 (0.24-2.36) 0.786
Renal diseases 24 (14.3) 13 (20.6) 1.56 (0.74-3.29) 0.241
Connective tissue  4 (2.4) 3 (4.8) 2.05 (0.45-9.23) 0.394
diseases
Diabetes mellitus 23 (13.7) 14 (22.2) 1.80 (0.86-3.77) 0.115
Admission* 100 (59.5) 51 (81.0) 2.89 (1.43-5.82) 0.002
Operation* 14 (8.3) 18 (28.6) 4.40 (2.03-9.53) <0.001
Mechanical  2 (1.2) 6 (9.5) 8.74 (1.72-44.52) 0.006
ventilation*
Table 2. Univariate analysis of risk factors associated with MRSA
bacteremiaMRSA in ER 685
although it tended to be higher in MRSA patients (Table 1).
Patients with indwelling catheterization (OR, 0.31; CI, 0.14-
0.66) showed a low mortality rate associated with this dis-
ease; this could be attributable to early removal of the pri-
mary infection site.
DISCUSSION
The epidemiology of MRSA infection is changing. Strains
of MRSA, which previously have been largely confined to
hospitals and long-term care facilities, are emerging in the
community (4, 18). 
This study characterizes the epidemiology of MRSA bac-
teremia from the community, defined as recovery of MRSA
from blood cultures within the first 72 hr of an ED visit. Pre-
vious reports in Korea found MRSA infection among patients
with community-acquired SAB to be less than 20% (8, 19).
Our data show a proportion of MRSA among patients with
SAB within the first 72 hr of ED visit to be 27.3%. 
So far, different patient populations have been the focus in
several studies. In those studies, they have discussed poten-
tial risk factors of MRSA infections at the time of admission
(20-22). These data indicated several predictor variables that
were independently associated with MRSA bacteremia. MR-
SA bacteremia at the time of the ED visit was independent-
ly associated with older age, a history of admission to a hos-
pital, and a history of surgery in the previous year. In our
study population, the most frequent underlying source for
MRSA bacteremia was infection from any type of catheter.
Perhaps this result can be attributed to the fact that our hos-
pital is a tertiary hospital with large numbers of patients with
malignancy, chronic renal failure, and old age (prone to cere-
brovascular accident or dementia).
Treatment of serious S. aureus infections can be challeng-
ing, and the associated mortality rate remains between 20
to 50 percent despite the availability of highly active antimi-
crobial agents (23, 24). In our study, the overall mortality of
SAB seen in the ED was 22.5%. 
The choice of agents is problematic since widespread use
of glycopeptides in pending results from blood cultures is
likely to raise the cost, spread of resistance, and affect the
greater drug toxicity (25, 26). Of the 68 patients with MRSA
bacteremia in this study, 30 (47.6%) were initially prescribed
-lactam drugs, to which the organism was resistant. Of the
168 patients with MSSA bacteremia, 53 (31.5%) were ini-
tially prescribed glycopeptide agents. This is similar to the
results of other studies of SAB in which there were no differ-
ences in MSSA and MRSA mortality rates (13, 19, 27).
Effective antibiotic therapy and risk assessment may be
needed, along with good infection control practices, to reduce
the incidence of MRSA.
Several potential limitations should be considered when
interpreting our results. Because this was a retrospective pre-
valence study, the temporal relationship between the acqui-
sition of MRSA and exposure to medical attention was un-
certain. Moreover, the prevalence of MRSA in the commu-
nity at our ED may be substantially different from other
Korean communities. The population at this hospital may
be skewed because our hospital is a large, academic tertiary
center. Nonetheless, this study is the first report concerning
the prevalence, and risk factors of MRSA bacteremia ascer-
tained through ED visits in Korea.
In summary, methicillin resistance was not uncommon in
SAB among patients from our ED population. The propor-
tion of MRSA among SAB seen at ED visit increased signif-
icantly over the study period. Risk factors for MRSA identi-
fied in this study were older age (over 61 yr), previous hospi-
talization, and a history of surgery. These factors can be help-
ful in the selection of empirical antimicrobial agents. A pro-
spective study with a larger population is needed to overcome
possible geographic variations in the epidemiology of MRSA
colonization and/or infection in non-hospitalized or hospital-
ized populations.
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